Načítá se...
Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Edice: | Кардиоваскулярная терапия и профилактика |
| Témata: | |
| On-line přístup: | https://cardiovascular.elpub.ru/jour/article/view/1497 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|